NASDAQ:KOD (Kodiak Sciences)

About KOD

Kodiak's portfolio of candidate eye treatments centers on its innovative antibody biopolymer conjugate platform.
  • Kodiak Sciences (NASDAQ: KOD) Latest News

    No posts found.